Gerald L. Ray & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Gerald L. Ray & Associates's BMY Position: Q3 2017 in Review
Gerald L. Ray & Associates increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q3 2017, buying an estimated $184K and bringing the position to 174,805 shares worth $11.1M. The position accounts for 1.39% of the portfolio, ranked #11.
Gerald L. Ray & Associates first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Gerald L. Ray & Associates held 174,805 shares of Bristol-Myers Squibb worth $11.1M as of Q3 2017.
- Gerald L. Ray & Associates bought 3,150 Bristol-Myers Squibb shares in Q3 2017, an estimated $184K.
- Bristol-Myers Squibb made up 1.39% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #11 holding.
- Gerald L. Ray & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.